These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24704453)

  • 1. Alternative splicing variants of human Fbx4 disturb cyclin D1 proteolysis in human cancer.
    Chu X; Zhang T; Wang J; Li M; Zhang X; Tu J; Sun S; Chen X; Lu F
    Biochem Biophys Res Commun; 2014 Apr; 447(1):158-64. PubMed ID: 24704453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex.
    Lin DI; Barbash O; Kumar KG; Weber JD; Harper JW; Klein-Szanto AJ; Rustgi A; Fuchs SY; Diehl JA
    Mol Cell; 2006 Nov; 24(3):355-66. PubMed ID: 17081987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A splice variant of Skp2 is retained in the cytoplasm and fails to direct cyclin D1 ubiquitination in the uterine cancer cell line SK-UT.
    Ganiatsas S; Dow R; Thompson A; Schulman B; Germain D
    Oncogene; 2001 Jun; 20(28):3641-50. PubMed ID: 11439327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Fbx4 tumor suppressor regulates cyclin D1 accumulation and prevents neoplastic transformation.
    Vaites LP; Lee EK; Lian Z; Barbash O; Roy D; Wasik M; Klein-Szanto AJ; Rustgi AK; Diehl JA
    Mol Cell Biol; 2011 Nov; 31(22):4513-23. PubMed ID: 21911473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation-dependent regulation of SCF(Fbx4) dimerization and activity involves a novel component, 14-3-3ɛ.
    Barbash O; Lee EK; Diehl JA
    Oncogene; 2011 Apr; 30(17):1995-2002. PubMed ID: 21242966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCF(Fbx4/alphaB-crystallin) E3 ligase: when one is not enough.
    Barbash O; Diehl JA
    Cell Cycle; 2008 Oct; 7(19):2983-6. PubMed ID: 18818515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in Fbx4 inhibit dimerization of the SCF(Fbx4) ligase and contribute to cyclin D1 overexpression in human cancer.
    Barbash O; Zamfirova P; Lin DI; Chen X; Yang K; Nakagawa H; Lu F; Rustgi AK; Diehl JA
    Cancer Cell; 2008 Jul; 14(1):68-78. PubMed ID: 18598945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FBX4 mediates rapid cyclin D1 proteolysis upon DNA damage in immortalized esophageal epithelial cells.
    Liu J; Yang H; Cheung PY; Tsao SW; Lv L; Cheung ALM
    Biochem Biophys Res Commun; 2021 May; 554():76-82. PubMed ID: 33784509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical role for FBXW8 and MAPK in cyclin D1 degradation and cancer cell proliferation.
    Okabe H; Lee SH; Phuchareon J; Albertson DG; McCormick F; Tetsu O
    PLoS One; 2006 Dec; 1(1):e128. PubMed ID: 17205132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoplastic hepatocyte growth associated with cyclin D1 redistribution from the cytoplasm to the nucleus in mouse hepatocarcinogenesis.
    Yamamoto M; Tamakawa S; Yoshie M; Yaginuma Y; Ogawa K
    Mol Carcinog; 2006 Dec; 45(12):901-13. PubMed ID: 17013836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine 269 is essential for cyclin D1 ubiquitylation by the SCF(Fbx4/alphaB-crystallin) ligase and subsequent proteasome-dependent degradation.
    Barbash O; Egan E; Pontano LL; Kosak J; Diehl JA
    Oncogene; 2009 Dec; 28(49):4317-25. PubMed ID: 19767775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.
    Kim JK; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Ahn YM; Ryu JC; Park WS; Lee JY; Nam SW
    Int J Oncol; 2009 Dec; 35(6):1257-64. PubMed ID: 19885547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine Suppresses Cyclin D1 Expression through Proteasomal Degradation in Human Hepatoma Cells.
    Wang N; Wang X; Tan HY; Li S; Tsang CM; Tsao SW; Feng Y
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ursolic acid on MAPK in cyclin D1 signaling and RING-type E3 ligase (SCF E3s) in two endometrial cancer cell lines.
    Achiwa Y; Hasegawa K; Udagawa Y
    Nutr Cancer; 2013; 65(7):1026-33. PubMed ID: 24083669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells.
    Kim CJ; Nishi K; Isono T; Okuyama Y; Tambe Y; Okada Y; Inoue H
    Mol Carcinog; 2009 Oct; 48(10):953-64. PubMed ID: 19415719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.
    Lu F; Gladden AB; Diehl JA
    Cancer Res; 2003 Nov; 63(21):7056-61. PubMed ID: 14612495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulated expression of atypical PKC-binding domain deleted asip isoforms in human hepatocellular carcinomas.
    Fang CM; Xu YH
    Cell Res; 2001 Sep; 11(3):223-9. PubMed ID: 11642408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitory effect of wild-type RASSF1A gene expression on proliferation of hepatocellular carcinoma QGY-7703 cells].
    Rui L; Xue WJ; Li P; Wang ZW; Wang P; Li HX
    Ai Zheng; 2008 Sep; 27(9):924-8. PubMed ID: 18799029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of cytoplasmic cyclin D1 mutants.
    Murakami H; Horihata M; Andojo S; Yoneda-Kato N; Kato JY
    FEBS Lett; 2009 May; 583(10):1575-80. PubMed ID: 19409388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Sirpalpha1 on the expression of nuclear factor-kappa B in hepatocellular carcinoma.
    Qin JM; Wan XW; Zeng JZ; Wu MC
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):276-83. PubMed ID: 17548251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.